Ebolavirus and haemorrhagic syndrome

Gerald A. Matua, Dirk M. Van Der Wal, Rozzano C. Locsin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world’s most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Zaïre, Reston and Taï Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies.

Original languageEnglish
Pages (from-to)e171-e176
JournalSultan Qaboos University Medical Journal
Volume15
Issue number2
Publication statusPublished - May 1 2015

Fingerprint

Ebolavirus
Viruses
Bioterrorism
Sudan
Hominidae
Disease Management
Allergy and Immunology
Ecology
Shock
Fever
Vaccines
Anxiety
RNA
Therapeutics

Keywords

  • Disease management
  • Ebola
  • Ebolavirus
  • Filoviridae
  • Hemorrhage
  • Hemorrhagic fever
  • Pathogenicity factors
  • Virulence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Matua, G. A., Van Der Wal, D. M., & Locsin, R. C. (2015). Ebolavirus and haemorrhagic syndrome. Sultan Qaboos University Medical Journal, 15(2), e171-e176.

Ebolavirus and haemorrhagic syndrome. / Matua, Gerald A.; Van Der Wal, Dirk M.; Locsin, Rozzano C.

In: Sultan Qaboos University Medical Journal, Vol. 15, No. 2, 01.05.2015, p. e171-e176.

Research output: Contribution to journalArticle

Matua, GA, Van Der Wal, DM & Locsin, RC 2015, 'Ebolavirus and haemorrhagic syndrome', Sultan Qaboos University Medical Journal, vol. 15, no. 2, pp. e171-e176.
Matua GA, Van Der Wal DM, Locsin RC. Ebolavirus and haemorrhagic syndrome. Sultan Qaboos University Medical Journal. 2015 May 1;15(2):e171-e176.
Matua, Gerald A. ; Van Der Wal, Dirk M. ; Locsin, Rozzano C. / Ebolavirus and haemorrhagic syndrome. In: Sultan Qaboos University Medical Journal. 2015 ; Vol. 15, No. 2. pp. e171-e176.
@article{d226cec086944cdc87a9d7758e32d158,
title = "Ebolavirus and haemorrhagic syndrome",
abstract = "The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world’s most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90{\%} of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Za{\"i}re, Reston and Ta{\"i} Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies.",
keywords = "Disease management, Ebola, Ebolavirus, Filoviridae, Hemorrhage, Hemorrhagic fever, Pathogenicity factors, Virulence",
author = "Matua, {Gerald A.} and {Van Der Wal}, {Dirk M.} and Locsin, {Rozzano C.}",
year = "2015",
month = "5",
day = "1",
language = "English",
volume = "15",
pages = "e171--e176",
journal = "Sultan Qaboos University Medical Journal",
issn = "2075-051X",
publisher = "Sultan Qaboos University",
number = "2",

}

TY - JOUR

T1 - Ebolavirus and haemorrhagic syndrome

AU - Matua, Gerald A.

AU - Van Der Wal, Dirk M.

AU - Locsin, Rozzano C.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world’s most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Zaïre, Reston and Taï Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies.

AB - The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world’s most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Zaïre, Reston and Taï Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies.

KW - Disease management

KW - Ebola

KW - Ebolavirus

KW - Filoviridae

KW - Hemorrhage

KW - Hemorrhagic fever

KW - Pathogenicity factors

KW - Virulence

UR - http://www.scopus.com/inward/record.url?scp=84930061535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930061535&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84930061535

VL - 15

SP - e171-e176

JO - Sultan Qaboos University Medical Journal

JF - Sultan Qaboos University Medical Journal

SN - 2075-051X

IS - 2

ER -